🩺 Bringing bispecific antibody therapy into community practice?
ImpleMMent offers customized virtual education to help oncology teams safely deliver BsAbs.
🎓 Free CE
🔗 Apply: info.cmeoutfitters.com/gr-13…
#MultipleMyeloma #CME
8
⏱️ Make your CME time count.
Precision Learning Clinical Simulations meet you where you are, creating a more personalized, interactive educational experience built around clinical decision-making.
Get started: cmeo.me/COP-Activities
#PrecisionLearning #CME
Keeping up with medicine shouldn't mean putting life on hold.
At Efficient, we develop accredited CME designed to fit the realities of modern clinical practice, making it easier to stay current through flexible, engaging educational experiences.
Follow us for:
📚 New CME activities
💡 Clinical education highlights
📅 Upcoming live events
🏅 Opportunities to earn CME/CE credit
Start exploring today: cmeo.me/ECME
#MedicalEducation #HealthcareLearning #CME
1
🎯 Ready to integrate bispecific antibodies into practice?
Gain real-world experience through expert-guided cases and interactive simulations.
👉 cmeo.me/SIM-002
#MultipleMyeloma #BispecificAntibodies #MedEd
3
Replying to @EfficientCme @SKriegerMD
“When patients experience PIRA, they have already atrophied. We need to act before PIRA. So the question is can we identify patients who would benefit before it happens.” – Dr Granziera
7
Replying to @EfficientCme @SKriegerMD
“There’s a lot that we’re going to have to figure out in the real world with BTKis and that makes our lives interesting.” – Dr Freeman
1
8
Replying to @EfficientCme @SKriegerMD
"Our polling question is: with the understanding that relapse and progression can occur together, are there circumstances in which you can just target relapse or just target progression?…It is a 49%/51% room…so if there were ever evidence of dis-consensus in the field of multiple sclerosis, you got it." – Dr Krieger
1
13
Replying to @EfficientCme @SKriegerMD
"Our polling question is: with the understanding that relapse and progression can occur together, are there circumstances in which you can just target relapse or just target progression?…It is a 49%/51% room…so if there were ever evidence of dis-consensus in the field of multiple sclerosis, you got it." – Dr Krieger @SKriegerMD
1
20
Replying to @EfficientCme @SKriegerMD
"Now I would like to demystify the thinking that PRLs and CVS are advanced biomarkers…I would like to ask you how many of you have an SWI sequence in your stroke protocol? That’s exactly what you need. So it’s the same type of acquisition, different protocol...If the stroke people are doing it, why can’t we?" - Dr Granziera
1
12
Replying to @EfficientCme @SKriegerMD
"There’s contrast with our clinical reality...I feel like Dr Jekyll and Mr Hyde. I think of MS as one disease and then I step into the clinic and have to choose a category to classify my patients." - Dr Freeman
1
16
Replying to @EfficientCme @SKriegerMD
"What we saw was that in this stable population of patients, the presence of 4 or more PRLs lead to an increase in s-NfL. So, there is ongoing neurodegeneration in patients who we think are stable…and this was scary for me, but it is also very strong evidence that we need to do better classifying our patients and providing treatment." - Dr Granziera
1
14
Replying to @EfficientCme @SKriegerMD
Stay tuned for faculty quotes during today’s session!
"Apparently ~70% of you do not feel we are ready to eliminate MS phenotypes entirely." - Dr Krieger
@SKriegerMD
1
12
Happy Thursday!
We are in Toronto getting ready for our session: Treating All of MS: Unifying Strategies to Target Relapse and Progression in a Shifting Clinical Landscape.
Faculty include Dr. Stephen Krieger, Dr. Cristina Granziera, and Dr. Leorah Freeman.
Learn more: cmeo.me/MM-164
@SKriegerMD
#MultipleSclerosis #MS #Neurology
#Neuroimmunology #MedicalEducation
💬 What if CME felt more like practicing than completing another module?
Work through realistic clinical conversations, make decisions & engage with learning shaped by your responses.
Try Precision Learning: cmeo.me/COP-Activities
#MedicalEducation #CME
7
Learning made simpler. Education made more meaningful.
Efficient was created to help healthcare professionals access accredited education that's engaging, flexible, and immediately applicable to clinical practice.
Create a free account to:
✅ Access live and on-demand activities
✅ Track your learning progress
✅ Download CME/CE certificates
And don't forget to follow us on social media so you never miss a new activity or educational update.
🔗 cmeo.me/ECME
#CME #ContinuingEducation #HealthcareProfessionals
10
🩸 Bispecific antibodies are transforming RRMM care.
Learn practical strategies for patient selection, sequencing, and toxicity management.
👉 cmeo.me/SIM-002
#MultipleMyeloma #Oncology #Hematology
4
🎯 Personalized CME. Built around you.
Precision Learning Clinical Simulations use interactive, case-based experiences to help you apply clinical evidence to real-world decisions.
Explore a different kind of CME: cmeo.me/COP-Activities
#PrecisionLearning #CME
7
Education should fit into your day, not the other way around.
That's the philosophy behind Efficient. We create accredited CME activities that respect clinicians' busy schedules while delivering timely, practice-focused education that supports better patient care.
Follow our social media pages to discover the latest activities, expert insights, and new learning opportunities.
Explore available activities: cmeo.me/ECME
#HealthcareEducation #CME #ProfessionalDevelopment #MedEd
1
1
5
💊 Build confidence with hands-on learning.
Apply evidence-based strategies for bispecific antibody therapy through interactive simulations and expert coaching.
👉 cmeo.me/SIM-002
#BispecificAntibodies #Oncology
6




